$12.00
-1.75 (-12.73%)
Open$14.03
Previous Close$13.75
Day High$14.03
Day Low$12.00
52W High$2,235.00
52W Low—
Volume—
Avg Volume26.2K
Market Cap21.92M
P/E Ratio—
EPS$-777.12
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 10.61M | 10.68M | 9.55M |
| Net Income | 789.2K | 807.9K | 770.6K |
| Profit Margin | 7.4% | 7.6% | 8.1% |
| EBITDA | 1.40M | 1.47M | 1.23M |
| Free Cash Flow | 547.8K | 770.2K | 737.4K |
| Rev Growth | -2.0% | +19.5% | +10.5% |
| Debt/Equity | 0.36 | 0.38 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.87 | -1.20% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $354.05 | +0.63% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.73 | +0.98% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $449.71 | +0.71% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $776.21 | +0.46% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.03 | -0.25% | 139.7 | 43.84B |